Prevalence and determinants of prehypertension status in the Taiwanese general population

Journal of Hypertension

Volumn 23, Issue 7, 2005, Pages 1355-1360

  Tsai, Pei Shan ^a,d   Ke, Tian Lu ^b   Huang, Chun Jen ^a,c   Tsai, Jen Chen ^a   Chen, Ping Ling ^a   Wang, Shu Yi ^a   Shyu, Yuh Kae ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b UNIVERSITY OF TAIPEI   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d NONE   (Taiwan)

Author keywords

Anthropometrics; Central obesity; General obesity; Prehypertension determinants

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANTHROPOMETRY; BODY MASS; DEMOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PREHYPERTENSION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SMOKING; STATISTICAL ANALYSIS; TAIWAN; VASCULAR DISEASE;

EID: 21644461114     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000173517.68234.c3     Document Type: Review

References (23)

1. Pan WH, Chang HY, Yeh WT, Hsiao SY, Hung YT. Prevalence, awareness, treatment and control of hypertension in Taiwan: results of Nutrition and Health Survey in Taiwan (NAHSIT) 1993-1996. J Hum Hypertens 2001; 15:793-798.
2. JNC VI. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH publication no. 90-4080. Washington, DC: US Department of Health and Human Services; 1997, pp. 11-18.
3. JNCVII. The seventh report of the Joint National committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, NIH Publication no. 04-5230. Washington, DC: US Department of Health and Human Services; 2004.
4. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1990-2000. Arch Intern Med 2004; 164:2113-2118.
5. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the New Joint National Committee Guidelines. Arch Intern Med 2004; 164:2126-2134.
6. Pan WH, Kao MD, Tzeng MS, Yen LL, Hung YT, Li LA, et al. Nutrition and Health Survey in Taiwan (NAHSIT) 1993-1996: Design, contents, and operations. Nutr Sci J 1999; 24:1-10.
7. Chang HY, Yeh WT, Chang YH, Tai KS, Pan WH. Prevalence of dyslipidemia and mean blood lipid values in Taiwan: results from the Nutrition and Health Survey in Taiwan (NAHSIT, 1993-1996). Chin J Physiol 2002; 45:187-197.
8. Lidfeldt J, Nyberg P, Nerbrand C, Samsioe G, Schersten B, Agardh CD, et al. Socio-demographic and psychosocial factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study. Diabetes Obes Metab 2003; 5:106-112.
9. National Institute on Alcohol Abuse and Alcoholism. Health risks and benefits of alcohol consumption. Tenth Special Report to the US Congress on Alcohol and Health 2000; 1:5-11.
10. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32:S498-S504.
11. Santos AC, Barros H. Prevalence and determinants of obesity in an urban sample of Portuguese adults. Public Health 2003; 117:430-437.
12. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345:1291-1297.
13. Solymoss BC, Bourassa MG, Campeau L, Sniderman A, Marcil M, Lesperance J, et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol 2004; 3:159-164.
14. Baltali M, Gokcel A, Kiziltan HT, Korkmaz ME, Topcu S, Yalcin F, et al. Association between the metabolic syndrome and newly diagnosed coronary artery disease. Diabetes Nutr Metab 2003; 16:169-175.
15. Marroquin OC, Kip KE, Kelley DE, Johnson BD, Shaw LJ, Bairey Merz CN, et al. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation 2004; 109:714-721.
16. Katzmarzyk PT. The Canadian obesity epidemic: an historical perspective. Obes Res 2002; 10:666-674.
17. Kim Y, Suh YK, Choi H. BMI and metabolic disorders in South Korean adults: 1998 Korea National Health and Nutrition Survey. Obes Res 2004; 12:445-453.
18. Lissner L, Johansson SE, Qvist J, Rossner S, Wolk A. Social mapping of the obesity epidemic in Sweden. Int J Obes Relat Metab Disord 2000; 24:801-805.
19. Lee ZS, Critchley JA, Ko GT, Anderson PJ, Thomas GN, Young RP, et al. Obesity and cardiovascular risk factors in Hong Kong Chinese. Obes Rev 2002; 3:173-182.
20. Jia WP, Xiang KS, Chen L, Lu JX, Wu YM. Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China. Obes Rev 2002; 3:157-165.
21. Chien LY, Liou YM, Chen JJ. Association between indices of obesity and fasting hyperglycemia in Taiwan. Int J Obes Relat Metab Disord 2004; 28:690-696.
22. He J, Whelton PK, Appel LJ, Charleston J, Klag MJ. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 2000; 35:544-549.
23. Okosun IS, Boltri JM, Anochie LK, Chandra KMD. Racial/ethnic differences in prehypertension in American adults: Population and relative attributable risks of abdominal obesity. J Hum Hypertens 2004; 18:849-855.